Clinical Trial Update: Combined Treatment of Resistant Hypertension and Atrial Fibrillation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combined treatment approach for resistant hypertension and atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Hypertension

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Hypertension, Resistant to Conventional Therapy, Atrial Fibrillation | Phase 2 | Status: COMPLETED